Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-11-17

Clinical Trial Update: Transcranial Alternating Current Stimulation for Patients With Mild Alzheimer's Disease II (TRANSFORM-AD II) [NA]

View source ↗

Summary

TRANSFORM-AD II investigates transcranial alternating current stimulation in patients with mild Alzheimer's disease. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Alzheimer Disease | NA | Status: NOT_YET_RECRUITING